Search alternatives:
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
-
2181
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2182
-
2183
-
2184
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2185
-
2186
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2187
-
2188
-
2189
-
2190
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2191
-
2192
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2193
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2194
-
2195
-
2196
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2197
-
2198
-
2199
-
2200